Skip to main content
  • English
  • Español
Home
  • Company
    • Overview & History
    • Team
    • Join Oryzon
  • Epigenetics
    • Histone Code Hypothesis
    • Modulator Enzymes
    • LSD1 & Disease
    • Technology Platforms
    • Scientific Publications by Oryzon
  • Therapeutic Programs
    • Strategy
    • LSD1 & Cancer
    • LSD1 & CNS
    • Oryzon's Pipeline
  • Collaborative Research
    • Collaborative Projects
  • For Patient
    • Patient Information
  • Shareholders and Investors
    • Investor Information and News
    • Share Information
    • Events & Presentations
    • Financial Information & Downloads
    • Analyst Coverage
    • Corporate Governance
    • Corporate Social Responsibility
  • News & Press Releases
  • Contact
    • General Contact
    • Investor Contact
    • Email Alerts

investors

Shareholders and Investors

  • Investor Information and News
  • Share Information
  • Events & Presentations
  • Financial Information & Downloads
  • Analyst Coverage
  • Corporate Governance
  • Corporate Social Responsibility
  • Shareholders Annual General Meeting
  • Board of Directors
  • Board Committees
  • Agreements Between Significant Shareholders
  • Annual Corporate Governance Reports
  • Annual Director Remuneration Report

Annual Corporate Governance Reports

In this section you will find the Annual Corporate Governance Reports sent to the Spanish National Securities Market Commission (CNMV) for downloading.

  • Español
Date Title
15 February 2019 PDF icon Corporate Governance Annual Report 2018 (Spanish)
19 February 2018 PDF icon Corporate Governance Annual Report 2017 (Spanish)
24 February 2017 PDF icon Corporate Governance Annual Report 2016 (Spanish)
29 February 2016 PDF icon Corporate Governance Annual Report 2015 (Spanish)

epigen-logo

Epigenetic drugs for a better world.

United States

Oryzon Corporate
245 First Street, Suite 1800
Cambridge, MA 02142

T: (617) 444-8786
F: (617) 444- 8405
info@oryzon.com

Spain

Oryzon Genomics
Sant Ferran 74
08940 Cornellà de Llobregat, Barcelona, Spain

T: (+34) 93 515 1313
F: (+34) 93 377 4028
info@oryzon.com

Legal Advice
Privacy Policy

Investor Information

ISIN: ES0167733015 - ORY

Please contact us for investor information.

Contact Us

© 2019

Oryzon Genomics

All Rights Reserved

  • Legal Advice
  • Privacy Policy
  • Registered address: Carrera de San Jerónimo 15, 2ª planta, 28014 Madrid (Spain)